Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 4;30(15):3264.
doi: 10.3390/molecules30153264.

Efficient Approaches to the Design of Six-Membered Polyazacyclic Compounds-Part 1: Aromatic Frameworks

Affiliations
Review

Efficient Approaches to the Design of Six-Membered Polyazacyclic Compounds-Part 1: Aromatic Frameworks

Elena A Gyrgenova et al. Molecules. .

Abstract

This review summarises the possible applications and basic methodologies for the synthesis of six-membered polyazo heterocycles, namely, diazines, triazines, and tetrazines. The time period covered by the analysed works ranges from the beginning of the 20th century to the present day. This period was chosen because it was during this time that synthetic chemistry, as defined by physicochemical research methods, became capable of solving such complex problems as efficiently as possible. The first part of the review describes the applications of polyazo heterocyclic compounds, whose frameworks are found in the composition of drugs, dyes, and functional molecules for materials chemistry, as well as in a wide variety of natural compounds and their synthetic analogues. The review also systematises the methods for assembling six-membered aromatic polyazo heterocycles, including intramolecular and sequential cyclisation, which determine the possible structural and functional diversity based on the presence and arrangement of nitrogen atoms and the position of the corresponding substituents.

Keywords: azaheterocyclic; diazine; tetrazine; triazine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Six-membered heterocycles with two nitrogen atoms: (a) pyridazine, (b) pyrimidine, and (c) pyrazine.
Figure 2
Figure 2
Examples of registered medicinal products comprising a pyridazine moiety.
Figure 3
Figure 3
Examples of registered medicinal products comprising a pyrimidine fragment.
Figure 4
Figure 4
Examples of registered medicinal products comprising a pyrazine moiety.
Figure 5
Figure 5
Six-membered heterocycles with three nitrogen atoms: (a) 1,3,5-triazine, (b) 1,2,4-triazine, and (c) 1,2,3-triazine.
Figure 6
Figure 6
Examples of registered medicinal products comprising triazine moieties.
Figure 7
Figure 7
Types of six-membered heterocycles with four nitrogen atoms: (a) 1,2,3,4-tetrazine, (b) 1,2,3,5-tetrazine, and (c) 1,2,4,5-tetrazine.
Figure 8
Figure 8
Examples of registered drugs comprising tetrazine moieties.
Scheme 1
Scheme 1
General method for the synthesis of pyridazines [170,171,172,173,174].
Scheme 2
Scheme 2
General method for the synthesis of 4 from 3 via the Diels–Alder reaction [176,177,178].
Scheme 3
Scheme 3
One-pot [4+2] cyclocondensation of substituted pyridazines [188].
Scheme 4
Scheme 4
Pyridazine synthesised under green chemistry conditions using microwave irradiation [189].
Scheme 5
Scheme 5
Domino-coupling–isomerisation–condensation reaction [196].
Scheme 6
Scheme 6
One-pot synthesis of condensed 2H-pyrimidin-4-amine libraries under microwave irradiation [207].
Scheme 7
Scheme 7
Skeletal editing of indoles and pyrroles: (a) recyclarization of indole, and (b) recyclarization of pyrrole [210].
Scheme 8
Scheme 8
Electro-oxidative formal [3+3] annulation of 1,3,5-triazinane [211].
Scheme 9
Scheme 9
Cyclocondensation pyrroles with tosylmethylisocyanide [212].
Scheme 10
Scheme 10
One-pot three-component synthesis of pyrrolo[1,2-a]pyrimidine [213].
Scheme 11
Scheme 11
Construction of multisubstituted pyrrolo[1,2-a]pyrimidines [214].
Scheme 12
Scheme 12
(a) Cu-catalyzed synthesis and proposed mechanism of unsymmetrical pyrazines, and (b) proposed mechanism [219].
Scheme 13
Scheme 13
Co-catalyzed annulation of terminal alkynes and o-phenylenediamines [224].
Scheme 14
Scheme 14
Cyclisation reactions of 35 with allylamine and propargylamine [235].
Scheme 15
Scheme 15
Synthesis via a Knoevenagel/[4+1] cycloaddition cascade [236].
Scheme 16
Scheme 16
Microwave-assisted one-pot tandem reactions for direct conversion of primary aldehydes to triazines [241].
Scheme 17
Scheme 17
Condensation of acid chlorides or anhydrides 44 with salt 45 [242].
Scheme 18
Scheme 18
Copper-catalysed synthesis of substituted 2,4-diamino-1,3,5-triazines [243].
Scheme 19
Scheme 19
Reactivity of 1,2,3,5-tetrazines 50 [157].
Scheme 20
Scheme 20
The transformations to construct 1,2,4-triazine derivatives [246].
Scheme 21
Scheme 21
Synthesis of triazine derivative [247].
Scheme 22
Scheme 22
Multistep synthesis of pyrrolotriazine [248].
Scheme 23
Scheme 23
Two-step synthesis of pyrrolotriazine [249].
Scheme 24
Scheme 24
The base-mediated cyclisation of (Z)-2,4-diazido-2-alkenoates [250].
Scheme 25
Scheme 25
The [5+1] cycloaddition reaction for the directed synthesis of triazine-1-oxides [251].
Scheme 26
Scheme 26
Synthesis of 1,2,3,4-tetrazine [254].
Scheme 27
Scheme 27
(a,b) Two different methods of synthesis of cyclopenta-annulated 1,2,3,4-tetrazines [255].
Scheme 28
Scheme 28
Reaction of 3H-chromeno [2,3-d]pyrimidine with sodium azide [256].
Scheme 29
Scheme 29
Cycloadditions of aryl-N-sulphinylamines with substituted triazolium imides [258].
Scheme 30
Scheme 30
Synthesis of a monocyclic aromatic 1,2,3,5-tetrazine [259].
Scheme 31
Scheme 31
Synthesis of 1,2,3,5-tetrazines [157].
Scheme 32
Scheme 32
Pinner’s synthesis mechanism [264].
Scheme 33
Scheme 33
One-pot catalysed synthesis of 1,2,4,5-tetrazines directly from nitriles [265].
Scheme 34
Scheme 34
Synthesis of s-tetrazines [266].
Scheme 35
Scheme 35
Solid-phase synthesis of s-tetrazines [267].
Scheme 36
Scheme 36
Two-step synthesis of conjugated s-tetrazine derivatives [268].
Scheme 37
Scheme 37
Synthesis of pyrrolo[1,2-b][1,2,4,5]tetrazine [269,270,271].
Scheme 38
Scheme 38
Assembly of fused pyrrolopyrazinotetrazine ensembles and reversible fragmentation [272].

Similar articles

References

    1. Abida, Alam M.T., Asif M. Pharmacological activities of pyridoxines and pyridazinone Derivatives: A Review on biologically active scaffold. SAR J. Pharm. Sci. 2019;1:16–37. doi: 10.36346/sarjps.2019.v01i01.004. - DOI
    1. Liljebris C. Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B) Bioorg. Med. Chem. 2002;10:3197–3212. doi: 10.1016/S0968-0896(02)00176-1. - DOI - PubMed
    1. Asif M., Alghamdi S. A mini-review on pyridazine analogs: Chemical and pharmacological potentials. Mini Rev. Org. Chem. 2023;20:100–123. doi: 10.2174/1570193X19666220329155551. - DOI
    1. Natarajan R., Anthoni Samy H.N., Sivaperuman A., Subramani A. Structure-activity relationships of pyrimidine derivatives and their biological activity—A review. Med. Chem. 2022;19:10–30. doi: 10.2174/1573406418666220509100356. - DOI - PubMed
    1. Patil S.B. Recent medicinal approaches of novel pyrimidine analogs: A review. Heliyon. 2023;9:e16773. doi: 10.1016/j.heliyon.2023.e16773. - DOI - PMC - PubMed

LinkOut - more resources